secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0000950170-22-027017
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs receives Nasdaq deficiency notice for failing minimum equity requirement
--------------------------------------------------------------------------------

- Nasdaq letter dated Dec 21, 2022: stockholders' equity ($1.08M) below $2.5M minimum required by Listing Rule 5550(b)(1).
- Company has 45 days (until Feb 3, 2023) to submit a compliance plan; Nasdaq may grant up to 180 days to regain compliance.
- If plan not accepted or compliance not regained, trading suspension or delisting risk, negatively impacting liquidity and financing.
- Company intends to take measures to regain compliance; is evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017022027017/0000950170-22-027017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017022027017/hscs-20221223.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-027017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer